Microcaps closes its CHF 5m Seed Round
Microcaps closes a CHF 5 Million seed financing round co-lead by Helvetica Capital and Zürcher Kantonalbank. The ETH Zurich Foundation, the Lichtsteiner Foundation and a group of Swiss entrepreneurs participated significantly in the financing.
Microcaps is an ETH-spinoff that was founded in 2019 with its origination starting in 2018 when its co-founders Alessandro Ofner and Michael Hagander received the pioneer fellowship award from the ETH Zurich Foundation. The company's unique and patented technology allows the development and manufacturing of microcapsules at an unmatched precision and efficiency. This provides customers with tailored micro encapsulation solutions that enable precise release of contents. Offering individual benefits for different applications; controlled release, targeted delivery, and shear free encapsulation, the technology has its largest impact potential in the fields of pharmaceuticals, nutrition and cosmetics.
Microcaps closes a CHF 5 Million seed financing round co-lead by Helvetica Capital and Zürcher Kantonalbank. The ETH Zurich Foundation, the Lichtsteiner Foundation and a group of Swiss entrepreneurs participated significantly in the financing. BV4 acted as an independent due diligence advisor for a group of investors that participated in the transaction.